Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain
El-Agamy, Sara Emad; Abdel-Aziz, Amal Kamal; Esmat, Ahmed; Azab, Samar S;
Abstract
Chemobrain refers to a common sequela experienced by a substantial subset of cancer patients exposed to chemotherapeutic treatment, a phenomenon that dramatically deteriorates the survivors' quality of life and prevents them from restoring their pre-cancer life. This review is intended to address the current knowledge regarding the mechanisms underlying the pathophysiology of the chemobrain phenomenon, with special focus on the antineoplastic agent ''doxorubicin'', which has been shown to be implicated in strenuous central neurotoxicity despite being-almost entirely-peripherally confined. Moreover, the assessment of the post-chemotherapy cognitive impairment in both human and animal subjects, and the potential pharmacotherapy and behavioral intervention strategies are reviewed.
Other data
| Title | Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain | Authors | El-Agamy, Sara Emad; Abdel-Aziz, Amal Kamal ; Esmat, Ahmed; Azab, Samar S | Keywords | Doxorubicin;Neuropsychological tests;Memory;Hippocampus;Chemobrain | Issue Date | 2019 | Publisher | SPRINGER | Journal | Cancer chemotherapy and pharmacology | ISSN | 0344-5704 1432-0843 |
DOI | 10.1007/s00280-019-03827-0 | PubMed ID | 30955080 | Scopus ID | 2-s2.0-85064191229 | Web of science ID | WOS:000471238200001 |
Attached Files
| File | Description | Size | Format | Existing users please Login |
|---|---|---|---|---|
| El-Agamy2019_Article_ChemotherapyAndCognitionCompre.pdf | 1.5 MB | Adobe PDF | Request a copy |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.